The researchers of Imperial College, London are in the process of, developing an appetite suppressant drug, in the form of chewing gum. The chewing gum is to be used after food and is based on a body hormone used to address the problem of obesity. The research work, headed by Professor Steve Bloom has been awarded 2.3 million pounds, by Wellcome Trust.

Study Focus
a. The study is focusing on the role of regulatory peptides, hypothalamic growth hormones and neurotransmitters in maintaining energy balance in mammals.
b. To study appetite, energy balance mechanisms, adult gene manipulation and hypothalamic techniques are employed.
c. The study has shown positive results in understanding the role of peripheral peptide hormonal signals in gut, thus controlling appetite.
d. If successfully developed this natural appetite suppressant, mimics mind that stomach is full, thus averting the instinct to eat more.
e. It is safe and effective without any side effects.
f. Experts say that the product can be commercially available in about 5 to 8 years.